These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25435936)

  • 1. Craniopharyngioma: Survivin expression and ultrastructure.
    Zhu J; You C
    Oncol Lett; 2015 Jan; 9(1):75-80. PubMed ID: 25435936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
    Stache C; Bils C; Fahlbusch R; Flitsch J; Buchfelder M; Stefanits H; Czech T; Gaipl U; Frey B; Buslei R; Hölsken A
    Neurosurg Focus; 2016 Dec; 41(6):E14. PubMed ID: 27903123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome.
    Weiner HL; Wisoff JH; Rosenberg ME; Kupersmith MJ; Cohen H; Zagzag D; Shiminski-Maher T; Flamm ES; Epstein FJ; Miller DC
    Neurosurgery; 1994 Dec; 35(6):1001-10; discussion 1010-1. PubMed ID: 7885544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papillary craniopharyngioma: a clinicopathological study of 48 cases.
    Crotty TB; Scheithauer BW; Young WF; Davis DH; Shaw EG; Miller GM; Burger PC
    J Neurosurg; 1995 Aug; 83(2):206-14. PubMed ID: 7616262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Craniopharyngioma: a clinicopathological study of 141 cases.
    Tavangar SM; Larijani B; Mahta A; Hosseini SM; Mehrazine M; Bandarian F
    Endocr Pathol; 2004; 15(4):339-44. PubMed ID: 15681858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different keratin profiles in craniopharyngioma subtypes and ameloblastomas.
    Tateyama H; Tada T; Okabe M; Takahashi E; Eimoto T
    Pathol Res Pract; 2001; 197(11):735-42. PubMed ID: 11770017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas.
    Yoshimoto K; Hatae R; Suzuki SO; Hata N; Kuga D; Akagi Y; Amemiya T; Sangatsuda Y; Mukae N; Mizoguchi M; Iwaki T; Iihara K
    Neuropathology; 2018 Feb; 38(1):3-10. PubMed ID: 28840946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations.
    Sekine S; Shibata T; Kokubu A; Morishita Y; Noguchi M; Nakanishi Y; Sakamoto M; Hirohashi S
    Am J Pathol; 2002 Dec; 161(6):1997-2001. PubMed ID: 12466115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative immunohistochemical expression of β-catenin, EGFR, ErbB2, and p63 in adamantinomatous and papillary craniopharyngiomas.
    Esheba GE; Hassan AA
    J Egypt Natl Canc Inst; 2015 Sep; 27(3):139-45. PubMed ID: 26198262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suprasellar squamous papillary craniopharyngioma: a case report.
    Wu CY; Anderson SF
    Optometry; 2001 May; 72(5):299-308. PubMed ID: 11394840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathological and immunohistochemical characteristics associated to recurrence/regrowth of craniopharyngiomas.
    Tena-Suck ML; Salinas-Lara C; Arce-Arellano RI; Rembao-Bojórquez D; Morales-Espinosa D; Sotelo J; Arrieta O
    Clin Neurol Neurosurg; 2006 Oct; 108(7):661-9. PubMed ID: 16500745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of craniopharyngioma: an electron microscopic study.
    Kawano N; Oka H; Suwa T; Ito H; Yada K; Kameya T; Yagishita S
    Noshuyo Byori; 1993; 10(2):117-23. PubMed ID: 8220791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    Omay SB; Chen YN; Almeida JP; Ruiz-Treviño AS; Boockvar JA; Stieg PE; Greenfield JP; Souweidane MM; Kacker A; Pisapia DJ; Anand VK; Schwartz TH
    J Neurosurg; 2018 May; 128(5):1473-1478. PubMed ID: 28707994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localisation of cytokeratins in craniopharyngioma.
    Kurosaki M; Saeger W; Lüdecke DK
    Acta Neurochir (Wien); 2001; 143(2):147-51. PubMed ID: 11459086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM-1 expression in craniopharyngioma and Rathke's cleft cyst: its possible implication for controversial pathology.
    Liu Y; Wang CH; Li DL; Zhang SC; Peng YP; Peng JX; Song Y; Qi ST; Pan J
    Oncotarget; 2016 Aug; 7(31):50564-50574. PubMed ID: 27409178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study.
    Chen M; Zheng SH; Yang M; Chen ZH; Li ST
    J Neurooncol; 2018 May; 138(1):113-122. PubMed ID: 29388032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma.
    Paulus W; Honegger J; Keyvani K; Fahlbusch R
    Acta Neuropathol; 1999 Apr; 97(4):377-82. PubMed ID: 10208277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence].
    Pan J; Qi ST; Deng YJ; Ding YQ; Peng L; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):363-5. PubMed ID: 12390748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth of craniopharyngioma involving the third ventricular floor in relation to the hypothalamus].
    Liu BG; Qi ST; Pan J; Peng YP; Fang LX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):377-9. PubMed ID: 17425998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.